Xiaoying Lei
State Key Laboratory Of Holistic Integrative Management Of Gastrointestinal Cancers
Xi'an, China
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
CD48 is a novel immune checkpoint on tumour-associated macrophages in hepatocellular carcinoma.
Journal: Gut
Published: August 19, 2025
Targeting METTL8 with Rabdosiin overcomes lenvatinib resistance in hepatocellular carcinoma.
Journal: Experimental cell research
Published: August 17, 2024
Tumor Microenvironment-Responsive Nanocapsule Delivery CRISPR/Cas9 to Reprogram the Immunosuppressive Microenvironment in Hepatoma Carcinoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 12, 2024
CXCL12+ tumor-associated endothelial cells promote immune resistance in hepatocellular carcinoma.
Journal: Journal of hepatology
Published: March 25, 2024
Retraction Note: Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway.
Journal: Stem cell research & therapy
Published: September 29, 2023
Genotypes and Hot Spot Mutations of Hepatitis B Virus in Northwest Chinese Population and Its Correlation with Diseases Progression.
Journal: BioMed research international
Published: July 09, 2019
PLCE1 Polymorphisms and Risk of Esophageal and Gastric Cancer in a Northwestern Chinese Population.
Journal: BioMed research international
Published: September 21, 2018
Co-delivery nanocarriers targeting folate receptor and encapsulating 2-deoxyglucose and α-tocopheryl succinate enhance anti-tumor effect in vivo.
Journal: International journal of nanomedicine
Published: August 30, 2017
MOTS-c peptide increases survival and decreases bacterial load in mice infected with MRSA.
Journal: Molecular immunology
Published: June 15, 2017
Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway.
Journal: Stem cell research & therapy
Published: April 18, 2017
Androgen receptor‑mediated upregulation of quaking affects androgen receptor‑related prostate cancer development and anti‑androgen receptor therapy.
Journal: Molecular medicine reports
Published: March 13, 2017
Last Updated: 09/26/2026